New-Onset Alzheimer’s Disease and Normal Subjects 100% Separated Statistically by P300 and ICA

Previously, we described how patients with new-onset Alzheimer’s disease were differentiated from healthy, normal subjects to 100% accuracy, based on the amplitudes of the nonrhythmic back-projected independent components of the P300 peak at the electroencephalogram electrodes and their latency in t...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of Alzheimer's disease and other dementias Vol. 35; p. 1533317520935675
Main Authors Jervis, Barrie William, Bigan, Cristin, Besleaga, Mircea
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.01.2020
SAGE
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previously, we described how patients with new-onset Alzheimer’s disease were differentiated from healthy, normal subjects to 100% accuracy, based on the amplitudes of the nonrhythmic back-projected independent components of the P300 peak at the electroencephalogram electrodes and their latency in the response to an oddball, auditory evoked potential paradigm. A neural network and a voting strategy were used for classification. Here, we consider instead the statistical distribution functions of their latencies and amplitudes and suggest that the 2-sample Kolmogorov-Smirnov test based upon their latency distribution functions offers an alternative biomarker for AD, with their amplitude distribution at the frontal electrode fp2 as possibly another. The technique is general, relatively simple, and noninvasive and might be applied for presymptomatic detection, although further validation with more subjects, preferably in multicenter studies, is recommended. It may also be applicable to study the other P300 peaks and their associated interpretations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1533-3175
1938-2731
1938-2731
DOI:10.1177/1533317520935675